Product Information

EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.0725 per EA under NDC 31722073630. Its NADAC has been published 223 times since Aug 17, 2022.

FDA first approved this application on Jan 24, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
$1.0725per EA

Strength

600; 200; 300 mg/1; mg/1; mg/1

NDC

31722073630

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203053

FDA Approved

1/24/2022

TE Code

AB

On Market Since

1/24/2022

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A4 Inhibitors
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleosides
Nucleosides

Price Statistics

The NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has been published 223 times since Aug 17, 2022, and over the history we have for it it has declined 80.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0725 per EA
All-time high$5.4841 (Dec 14, 2022)
All-time low$1.0725 (Nov 18, 2026)
52-week high$1.4315
52-week low$1.0725
Median price$1.4315
Average price$2.2740
Largest weekly change-74.7% (Aug 23, 2023)
Weeks tracked223
Tracking sinceAug 17, 2022

Price History

1W

-3.2%

1M

-4.7%

3M

-7.9%

6M

-9.8%

1Y

-23.0%

3Y

-15.9%

5Y

N/A

All

-80.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $1.0725 per EA (NDC 31722073630), effective Nov 18, 2026.

How has the price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB changed over time?

Over the history we have for it, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has declined 80.4%. It has been tracked across 223 weekly CMS publications since Aug 17, 2022.

What are the highest and lowest recorded NADAC prices for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

Since Aug 17, 2022, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has ranged from a low of $1.0725 (Nov 18, 2026) to a high of $5.4841 (Dec 14, 2022), with a median of $1.4315 per EA.

Are there cheaper alternatives to EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB (NDC 31722073630) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.